交易 Sumitomo Dainippon Pharma Co., Ltd. - 4506 差價合約

交易條件

• 類型該金融市場可進行差價合約交易。了解更多：差價合約: 差價合約
• 點差: 4.2
• 長倉隔夜倉息調整長倉隔夜倉息調整保證金。您的投資¥1,000隔夜倉息來自頭寸全值的費用-0.01444 %(-¥3)使用杠杆的交易規模（大約值）¥20,000來自杠杆的資金 - 美元（大約值）¥19,000前往平台: -0.01444%
• 短倉隔夜倉息調整短倉隔夜倉息調整保證金。您的投資¥1,000隔夜倉息來自頭寸全值的費用-0.00778 %(-¥2)使用杠杆的交易規模（大約值）¥20,000來自杠杆的資金 - 美元（大約值）¥19,000前往平台: -0.00778%
• 隔夜倉息調整時間: 21:00 (UTC)
• 貨幣: JPY
• 最低成交量: 1
• 保證金: 5.00%
• 證券交易所: Japan
• 交易佣金: 0%
• 保證止損溢價保證止損 (GSL) 費用僅在 GSL 被觸發時收取。更多詳情請參閱我們網站的「服務費用」 頁面。: 1%

• 保證金。您的投資: ¥1,000
• 隔夜倉息來自頭寸全值的費用: -0.01444 %
  (-¥3)

• 保證金。您的投資: ¥1,000
• 隔夜倉息來自頭寸全值的費用: -0.00778 %
  (-¥2)

主要統計數據

• 前收盤價: 1893.9
• 開倉: 1931.3
• 1 年變化: 77.98%
• 日區間: 1931.3 - 1974.7

交易 Sumitomo Dainippon Pharma Co., Ltd. - 4506

Sumitomo Dainippon Pharma Co., Ltd. manufactures and sells pharmaceuticals, food ingredients and additives, veterinary medicines, diagnostics, and others. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, depression, type 2 diabetes, systemic fungal infection, pruritus, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It also provides atypical antipsychotic, antiepileptic, carbapenem antibiotic, and gastroprokine products; and Anderson-Fabry disease drugs. In addition, the company offers food ingredients and additives, such as polysaccharides, and seasonings, such as soups or bouillons; and chemical product materials consisting of pharmaceutical excipients, personal care products, coatings and industrial materials, and electronic materials. Further, it provides veterinary medicines for companion animals, primarily dogs and cats; and livestock comprising cattle, swine, poultry, horses, and aquacultured fish. Sumitomo Dainippon Pharma Co., Ltd. has partnerships with Healios K.K.; Keio University; RIKEN; the Center for iPS Cell Research and Application (CiRA); Kyoto University; and Aikomi Co., Ltd., as well as a joint development agreement with SanBio, Inc. The company was formerly known as Dainippon Sumitomo Pharma Co., Ltd. and changed its name to Sumitomo Dainippon Pharma Co., Ltd. in June 2014. Sumitomo Dainippon Pharma Co., Ltd. was founded in 1897 and is headquartered in Osaka, Japan. Sumitomo Dainippon Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.